Industry News

The Industry News page consists of Pre-Event Newsletters, Post-Event Reports, Whitepapers and Vendor News.

Whitepaper
The tumor microenvironment (TME) supports the development of pro-tumoral macrophages.
13 October 2021
Translational & Preclinical Development
Whitepaper
T cells can develop an exhausted phenotype as a result of prolonged antigen stimulation.
13 October 2021
Translational & Preclinical Development
Whitepaper
Dendritic cells (DC) are a unique population of myeloid cells that can activate naïve T cells through the formation of an immunological synapse presenting antigens.
13 October 2021
Translational & Preclinical Development
Whitepaper
Natural Killer (NK) cell-mediated cytotoxicity
13 October 2021
Translational & Preclinical Development
Whitepaper
Specialized immunohistochemical staining approaches utilized during preclinical and clinical drug discovery research provide valuable insights into the location and positioning of immuno-oncology biomarkers within the tumour and the tumour microenvironment (TME).
13 October 2021
Translational & Preclinical Development
Whitepaper
Concept Life Sciences has one of the largest chemistry groups in the UK working from state-of-the-art laboratories. They offer a comprehensive range of chemistry services to their clients and design and expedite routes to even the most challenging of targets.
13 October 2021
Translational & Preclinical Development
Whitepaper
To understand the mechanism and potency of novel drugs or cell therapies it is vital to assess not only the degree but also the dynamics of the target cell response.
13 October 2021
Translational & Preclinical Development
Whitepaper
Cell signaling via G-protein coupled receptors (GPCRs), and the downstream cellular processes, cause changes to cell attachment and morphology detectable through impedance measurements. Here, using the Maestro Z platform, we studied the dynamic response of Calu-3 cells to Isoproterenol, Histamine, and Cytochalasin D, revealing important information on the kinetics and mechanism of action for each treatment.
13 October 2021
Translational & Preclinical Development
Whitepaper
We offer a comprehensive panel of T cell assays that provide valuable efficacy data for the development of anti-inflammatory and anti-cancer therapies.
13 October 2021
Translational & Preclinical Development
Whitepaper
Mixed Lymphocyte Reaction (MLR) assays are commonly used to understand the effects of biologic and small molecule therapeutics on T cell activation - an important response in the tumor microenvironment (TME)
13 October 2021
Translational & Preclinical Development
Advertisement

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login